Skip to main content Accessibility help

GABA and acute psychoses1

  • Brian Meldrum
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      GABA and acute psychoses1
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      GABA and acute psychoses1
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      GABA and acute psychoses1
      Available formats


  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.



Hide All
Bird, E. D., Barnes, J., Iversen, L. L., Spokes, E. G., Mackay, A. V. P. & Shepherd, M. (1977). Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet ii, 11571159.
Bird, E. D., Spokes, E. G. S. & Iversen, L. L. (1979). Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain 102, 347360.
Bowen, D. M., Smith, C. B., White, P. & Davison, A. N. (1976). Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459496.
Bowers, M. B. (1974). Central dopamine turnover in schizophrenic syndromes. Archives of General Psychiatry 31, 5054.
Bowery, N. G. & Brown, D. A. (1974). Depolarizing actions of γ-amino-butyric acid and related compounds on rat superior cervical ganglia in vitro. British Journal of Pharmacology 50, 205218.
Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J. & Turnbull, M. (1980). (-)baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283, 9294.
Brennan, M. J. W. & Cantrill, R. C. (1979). δ-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature 280, 514515.
Brown, D. A. & Marsh, S. (1978). Axonal GABA-receptors in mammalian peripheral nerve trunks. Brain Research 156, 187191.
Carlsson, A. (1978). Antipsychotic drugs, neurotransmitters and schizophrenia. American Journal of Psychiatry 135, 164173.
Casey, D. E., Gerlach, J., Magelund, G. & Christensen, T. R. (1980). γ-acetylenic GABA in tardive dyskinesia. Archives of General Psychiatry 37, 13761380.
Chouinard, G. & Jones, B. D. (1978). Schizophrenia as dopamine-deficiency disease. Lancet ii, 99100.
Collins, G. G. S. (1980). Release of endogenous amino acid neurotransmitter candidates from rat olfactory cortex slices: possible regulatory mechanisms and the effects of pentobarbitone. Brain Research 190, 517528.
Cross, A. J., Crow, T. J. & Owen, F. (1979). Gamma-aminobutyric acid in the brain in schizophrenia. Lancet i, 560561.
Crow, T. J. (1978). Schizophrenia. The biochemistry of schizophrenia. British Journal of Hospital Medicine 20, 532544.
Crow, T. J., Baker, H. F., Cross, A. J., Joseph, M. H., Lofthouse, R., Longden, A., Owen, F., Riley, G. J., Glover, V. & Killpack, W. S. (1979). Monoamine mechanisms in chronic schizophrenia: post-mortem neuro-chemical findings. British Journal of Psychiatry 134, 249256.
Curtis, D. R. (1979). GABA-ergic transmission in the mammalian central nervous system. In GABA-Neurotransmitters (ed. Krogsgaard-Larsen, P., Scheel-Kruger, J. and Kofod, H.), pp. 1727. Munksgaard: Copenhagen.
Davis, K. E., Hollister, L. E. & Berger, P. A. (1976). Baclofen in schizophrenia. Lancet i, 1245.
Flor-Henry, P. (1969). Psychosis and temporal lobe epilepsy. Epilepsia 10, 363395.
Gallo, V., Levi, G., Raiteri, M. & Coletti, A. (1981). Enhancement by GABA of glutamate depolarization-induced release from cerebellar nerve endings. Brain Research 205, 431435.
Gerlach, J., Rye, T. & Kristjansen, P. (1978). Effect of baclofen on tardive dyskinesia. Psychopharmacology 56, 145151.
Gold, G. I., Bowers, M. B., Roth, R. H. & Sweeney, D. W. (1980), GABA levels in CSF of patients with psychiatric disorders. American Journal of Psychiatry 137, 362364.
Hare, T. A., Manyam, N. V. B. & Glaeser, B. S. (1980). Evaluation of cerebrospinal fluid γ-aminobutyric acid content in neurologic and psychiatric disorders. In Neurobiology of Cerebrospinal Fluid (ed. Wood, J. H.), p. 751. Plenum: New York.
Heath, R. G. (1954). Studies in Schizophrenia. Harvard University Press: Cambridge, Mass.
Lautin, A., Angrist, B., Stanley, M., Gershon, S., Heckl, K. & Karobath, M. (1980). Sodium valproate in schizophrenia: some biochemical correlates. British Journal of Psychiatry 137, 240244.
Lees, A. J., Shaw, K. M. & Stern, G. M. (1978). Baclofen in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 41, 707708.
Lichtshtein, D., Dobkin, J., Ebstein, R. P., Biederman, J., Rimon, R. & Belmaker, R. H. (1978). Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment. British Journal of Psychiatry 132, 145148.
McCarthy, B. W., Gomes, U. R., Neethling, A. C., Shanley, B. C., Taljaard, J. J. F., Potgieter, L. & Roux, J. T. (1981). γ-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia. Journal of Neurochemistry 36(4), 14061408.
McGeer, E. G. & McGeer, P. L. (1979). GABA-containing neurons in schizophrenia, Huntington's chorea and normal aging. In GABA-Neurotransmitters (ed. Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H.), pp. 340356. Munksgaard: Copenhagen.
McGeer, P. L., Brown, W. T. & Zeldowicz, L. (1977). Lack of effect of gamma-hydroxybutyrate in Huntington's chorea. Canadian Psychiatric Association Journal 22, 8789.
MacKay, A. V. P. (1980). Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry 137, 379386.
Manyam, N. V. B., Katz, L., Hare, T. A., Gerber, J. C. & Grossman, M. H. (1980). Levels of γ-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Archives of Neurology 37, 352355.
Meldrum, B. S. (1975). Epilepsy and γ-aminobutyric acid-mediated inhibition. International Review of Neurobiology 17, 136. Academic Press: New York.
Meldrum, B. S. (1979). Convulsant drugs, anticonvulsants and GABA-mediated neuronal inhibition. In GABA-Neurotransmitters (ed. Krogsgaard-Larsen, P., Scheel-Kruger, J. and Kofod, H.), pp. 390405. Munksgaard: Copenhagen.
Meldrum, B. (1981). Anticonvulsant drugs and GABA-mediated inhibition. In Psychopharmacology of Anticonvulsant drugs (ed. Sandler, M.). Oxford University Press: London.
Meldrum, B., Pedley, T., Horton, R., Anlezark, G. & Franks, A. (1980). Epileptogenic and anticonvulsant effects of GABA agonists and GABA uptake inhibitors. Brain Research Bulletin 5, Supplement 2, 685690.
Mitchell, P. R. & Martin, I. L. (1978). Is GABA release modulated by presynaptic receptors? Nature 274, 904905.
Olpe, H. R., Schellenberg, H. & Koella, W. P. (1977). Rotational behaviour induced in rats by intranigral application of GABA-related drugs and GABA antagonists. European Journal of Pharmacology 45, 291294.
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A. & Riley, G. J. (1978). Increased dopamine-receptor sensitivity in schizophrenia. Lancet ii, 223226.
Palfreyman, M. G., Schechter, P. J., Buckett, W. R., Tell, G. P. & Koch-Weser, J. (1981). The pharmacology of GABA-transaminase inhibitors. Biochemical Pharmacology 30, 817824.
Pepplinkuizen, L., Bruinvels, J., Blom, W. & Moleman, P. (1980). Schizophrenia-like psychosis caused by a metabolic disorder. Lancet i, 454456.
Perry, T. L., Buchanan, J., Kish, S. J. & Hansen, S. (1979). γ-aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet i, 237239.
Perry, T. L., Wright, J. M., Hansen, S., Allan, B. M., Baird, P. A. & MacLeod, P. M. (1980). Failure of amino-oxyacetic acid therapy in Huntington's disease. Neurology 30, 772775.
Post, R. M., Fink, E., Carpenter, W. T. & Goodwin, F. K. (1975). Cerebrospinal fluid amine metabolites in acute schizophrenia. Archives of General Psychiatry 32, 10631069.
Randrup, A. & Munkvad, I. (1972). Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomolecular Psychiatry 1, 227.
Roberts, E. (1976). Disinhibition as an organizing principle in the nervous system. The role of the GABA system. Application to neurologic and psychiatric disorders. In GABA in Nervous System Function (ed. Roberts, E., Chase, T. N. and Tower, D. B.), pp. 515539. Raven Press: New York.
Simpson, G. M., Branchey, M. H. & Shrivastana, R. K. (1976). Baclofen in schizophrenia. Lancet i, 966967.
Slater, E., Beard, A. W. & Glithero, E. (1963). The schizophrenia-like psychoses of epilepsy. British Journal of Psychiatry 109, 95150.
Spokes, E. G. S., Garrett, N. J., Rossor, M. N. & Iversen, L. L. (1980). Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects. Journal of Neurological Sciences 48, 303313.
Stevens, J., Wilson, K. & Foote, W. (1974). GABA blockade, dopamine and schizophrenia: experimental studies in the cat. Psychopharmacologia (Berlin) 39, 105119.
Sweeney, V. P., Pathak, M. A. & Asbury, A. K. (1970). Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack. Brain 93, 369380.
Tamminga, C. A., Crayton, J. W. & Chase, T. N. (1978). Muscimol: GABA agonist therapy in schizophrenia. American Journal of Psychiatry 135, 746747.
Tamminga, C. A., Crayton, J. W. & Chase, T. N. (1979). Suppression of involuntary movements in tardive dyskinesia by muscimol, a GABA agonist. Archives of General Psychiatry 36, 595598.
Tell, G., Böhlen, P., Schechter, P. J., Koch-Weser, J., Agid, Y., Bonnett, A. M., Coquillat, G., Chazot, G. & Fischer, C. (1981). Treatment of Huntington disease with γ-acetylenic GABA, an irreversible inhibitor of GABA transaminase: increased CSF GABA and homocarnosine without clinical amelioration. Neurology 31, 207211.
Van Kammen, D. P. (1977). γ-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. American Journal of Psychiatry 134, 138143.
Van Praag, H. M. (1977). The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenics. British Journal of Psychiatry 130, 463474.
Waser, P. G. (1967). The pharmacology of amanita muscaria.In Ethnopharmacologic Search for Psychoactive Drugs. Proceedings of a Symposium held in San Francisco California,28–30 January 1967 (ed. Efron, D. H., Holmstedt, B. and Kline, N. S.), pp. 419439.
Wolf, P., Olpe, H. R., Avrith, D. & Haas, H. L. (1978). GABA-ergic inhibition of neurons in the ventral tegmental area. Experientia 34, 73.
Wood, J. H., Hare, T. A., Glaeser, B. S., Ballenger, J. C. & Post, R. M. (1979). Low cerebrospinal fluid γ-aminobutyric acid content in seizure patients. Neurology 29, 12031208.
Yde, A., Lohse, E. & Faurbye, A. (1941). On the relation between schizophrenia, epilepsy and induced convulsions. Acta psychiatrica et neurologica scandinavica 16, 325388.

GABA and acute psychoses1

  • Brian Meldrum


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed